Approval of Daiichi Sankyo’s Vanflyta Sets Up FLT3 Head-To-Head Competition

 
• By Alaric DeArment
  
The FDA approved Daiichi Sankyo's Vanflyta in FLT3-ITD first-line AML • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip